Blood Biomarkers: Noncoding RNAs and Proteins
- PMID: 39637102
- Bookshelf ID: NBK609852
- DOI: 10.1093/med/9780197549469.003.0037
Blood Biomarkers: Noncoding RNAs and Proteins
Excerpt
The diagnosis of epilepsy and recent seizure remain important clinical challenges. Blood-based molecules represent potential circulating biomarkers that could provide simple, cheap, quick tests to support diagnosis, prognosis, monitoring, and decisions on choice and effectiveness of therapy. There have been recent and significant advances in identifying candidate molecules. A number of proteins hold promise, including HMGB1, matrix proteins, and neuron-enriched markers such as UCHL1. Small noncoding RNAs called microRNAs have more recently emerged, with interest stemming from their tissue-specific expression, suitability for rapid and quantitative assay, and link to mechanisms of disease and potential as treatments. Here we review why blood-based biomarkers are needed, the properties sought, and the quality and quantity of evidence obtained from clinical and experimental studies. We finish by identifying the necessary studies in the future that could bring these valuable supports to the clinic.
Sections
- Abstract
- Introduction
- Why Should Circulating Biofluids Contain Molecular Biomarkers of Epilepsy?
- Other Criteria That Must Be Met for Circulating Molecular Biomarkers
- What Type of Molecules Should We Be Looking for?
- How Would a Molecular Biomarker Be Used?
- miRNAs as Epilepsy Biomarkers
- Current Gaps—What We Know We Don’t Know
- Summary and Conclusions
- Acknowledgments
- Disclosure Statement
- References
References
-
- Abraira, L., Santamarina, E., Cazorla, S., Bustamante, A., Quintana, M., Toledo, M., Fonseca, E., Grau- Lopez, L., Jimenez, M., Ciurans, J., Luis Becerra, J., Millan, M., Hernandez- Perez, M., Cardona, P., Terceno, M., Zaragoza, J., Canovas, D., Gasull, T., Ustrell, X., Rubiera, M., Castellanos, M., Montaner, J. & Alvarezsabin, J. 2020. Blood biomarkers predictive of epilepsy after an acute stroke event. Epilepsia, 61, 2244–2253. - PubMed
-
- Alves De Lima, K., Rustenhoven, J. & Kipnis, J. 2020. Meningeal immunity and its function in maintenance of the central nervous system in health and disease. Annu Rev Immunol, 38, 597–620. - PubMed
-
- Andersen, P. & Moseklide, L. 1977. Immunoglobulin levels and autoantibodies in epileptics on long-term anticonvulsant therapy. Acta Med Scand, 201, 69–74. - PubMed
-
- Aronica, E., Fluiter, K., Iyer, A., Zurolo, E., Vreijling, J., Van Vliet, E. A., Baayen, J. C. & Gorter, J. A. 2010. Expression pattern of miR-146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsy. Eur J Neurosci, 31, 1100–7. - PubMed
-
- Arroyo, J. D., Chevillet, J. R., Kroh, E. M., Ruf, I. K., Pritchard, C. C., Gibson, D. F., Mitchell, P. S., Bennett, C. F., Pogosova-Agadjanyan, E. L., Stirewalt, D. L., Tait, J. F. & Tewari, M. 2011. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A, 108, 5003–8. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous